Corcept Therapeutics
CORT
#2417
Rank
A$9.34 B
Marketcap
$88.55
Share price
2.11%
Change (1 day)
147.93%
Change (1 year)

Corcept Therapeutics (CORT) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : A$0.25 Billion

According to Corcept Therapeutics 's latest financial reports the company's total liabilities are A$0.25 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Corcept Therapeutics - Total liabilities on balance sheet (from 2003 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$0.25 B53.56%
2023-12-31A$0.16 B40.56%
2022-12-31A$0.11 B81.27%
2021-12-31A$66.13 M5.09%
2020-12-31A$62.93 M7.13%
2019-12-31A$58.74 M15.56%
2018-12-31A$50.83 M34.22%
2017-12-31A$37.87 M-0.27%
2016-12-31A$37.97 M-17.18%
2015-12-31A$45.85 M-1.29%
2014-12-31A$46.45 M-1.48%
2013-12-31A$47.15 M31.06%
2012-12-31A$35.97 M634%
2011-12-31A$4.9 M28.99%
2010-12-31A$3.8 M41.12%
2009-12-31A$2.69 M-33.76%
2008-12-31A$4.06 M18.07%
2007-12-31A$3.44 M-23.38%
2006-12-31A$4.49 M-7.73%
2005-12-31A$4.86 M106.59%
2004-12-31A$2.35 M-95.95%
2003-12-31A$58.19 M-25.04%
2002-12-31A$77.62 M2002.81%
2001-12-31A$3.69 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$171.70 B 67,377.20%๐Ÿ‡บ๐Ÿ‡ธ USA
A$120.48 B 47,249.10%๐Ÿ‡บ๐Ÿ‡ธ USA
A$91.88 B 36,007.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$101.87 B 39,935.85%๐Ÿ‡บ๐Ÿ‡ธ USA
A$197.45 B 77,494.37%๐Ÿ‡บ๐Ÿ‡ธ USA
A$111.82 B 43,843.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.08 B 325.14%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.74 B 193.64%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.10 B 726.86%๐Ÿ‡บ๐Ÿ‡ธ USA